Dr. Jun Bao has over 25 years of combined business and R&D experiences. He currently serves as Chief Business Officer at Biotheus. Previously he was President & CEO of Impact Therapeutics. Prior to Impact, he served as SVP and CBO at Shenogen. He also served as Director, Worldwide Business Development, Head of China at GSK. Prior to GSK, he worked at Onyx Pharmaceuticals, ICOS and Cell Therapeutics as a business development executive with progressive responsibilities. He worked as finance manager in Procter & Gamble. He received BS in Microbiology from Shandong University and PhD in Neuroscience from University of Kansas. He received MBA from University of Chicago.